Skip to main content
. Author manuscript; available in PMC: 2021 Mar 18.
Published in final edited form as: ACS Chem Neurosci. 2020 Mar 3;11(6):960–968. doi: 10.1021/acschemneuro.0c00008

Figure 3.

Figure 3.

α-PHP is an antagonist/inverse agonist of M2R-β-arrestin recruitment with nanomolar potency. (A) Oxotremorine dose-dependently stimulated β-arrestin recruitment. (B) α-PHP blocked effects of oxotremorine (EC80 concentration) at M2Rs and, moreover, decreased β-arrestin recruitment below basal* levels, suggesting inverse agonist activity. Data are shown as normalized means (±SEM) of two, independent determinations, with oxotremorine tested at each concentration in duplicate and α-PHP tested in quadruplicate. [*Basal signaling is defined as the normalized RLUs emitted by untreated cells.]